SCHEMBL1597925

SCHEMBL1597925

O=C(ON(CC1CCCCN1)c1cnc2cccnc2n1)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.36
PTPN11 Q06124 1/20 0.34
LTA4H P09960 1/20 0.33
DPP4 P27487 1/20 0.33
DPP8 Q6V1X1 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNA4 P43681 1/20 0.33
PBK Q96KB5 1/20 0.32
SCN9A Q15858 1/20 0.32
MET P08581 1/20 0.32
CYP1A2 P05177 3/20 0.32
CYP2D6 P10635 3/20 0.32
CYP2C19 P33261 2/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1596721 0.93 CXCR3 (0.37) CXCR3PTPN11LTA4HCHRNB2CHRNA4
Trifluoroacetic Acid SCHEMBL1597922 0.74 DPP4 (0.40) DPP4DPP8DPP7CHRNB2CHRNA4
Trifluoroacetic Acid SCHEMBL1597918 0.73 PRMT5 (0.40) PTPN11DPP4DPP8DPP7HDAC4
Trifluoroacetic Acid SCHEMBL1596718 0.67 PTPN11 (0.40) PTPN11HDAC4HDAC6PBKMET
Trifluoroacetic Acid SCHEMBL1596720 0.66 DPP4 (0.36) PTPN11DPP4DPP8DPP7CHRNB2
Trifluoroacetic Acid SCHEMBL1241015 0.59 CHRNB2 (0.59) CHRNB2CHRNA4
SCHEMBL1598614 0.58 PRMT5 (0.46) CHRNB2CHRNA4CYP1A2CYP2D6CYP2C19
SCHEMBL4148589 0.57 PSEN1 (0.43) LTA4HCHRNB2CHRNA4CYP1A2CYP2D6
SCHEMBL22689036 0.56 SLC6A2 (0.42) CYP1A2CYP2D6CYP2C19CYP3A4CYP2C9
SCHEMBL1597414 0.55 PRMT5 (0.50) CHRNB2CHRNA4PBKCYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919507-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM LIMITED (GB) 2011-04-05 US disclosed
US-7741329-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM LIMITED (GB) 2010-06-22 US disclosed
US-20090093478-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.I.C. 2009-04-09 US disclosed
US-20090029986-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.L.C. 2009-01-29 US disclosed
US-20090012073-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.L.C. 2009-01-08 US disclosed
EP-1956020-A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity SMITHKLINE BEECHAM PLC (GB) 2008-08-13 EP disclosed
EP-1385845-B1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM PLC (GB) 2008-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012073-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB CXCR3 2048/4885PTPN11 1574/4885LTA4H 1852/4885
US-20090093478-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB CXCR3 2048/4885PTPN11 1574/4885LTA4H 1852/4885
US-20090029986-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB CXCR3 2048/4885PTPN11 1574/4885LTA4H 1852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.